LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS
Publication
, Conference
Roskoski, M; Gasinski, D; Friedman, H; Bigner, D; Keir, S
Published in: Neuro-Oncology
June 22, 2018
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 22, 2018
Volume
20
Issue
suppl_2
Start / End Page
i104 / i105
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Roskoski, M., Gasinski, D., Friedman, H., Bigner, D., & Keir, S. (2018). LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS. In Neuro-Oncology (Vol. 20, pp. i104–i105). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noy059.345
Roskoski, Martin, Danuta Gasinski, Henry Friedman, Darell Bigner, and Stephen Keir. “LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS.” In Neuro-Oncology, 20:i104–5. Oxford University Press (OUP), 2018. https://doi.org/10.1093/neuonc/noy059.345.
Roskoski M, Gasinski D, Friedman H, Bigner D, Keir S. LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS. In: Neuro-Oncology. Oxford University Press (OUP); 2018. p. i104–5.
Roskoski, Martin, et al. “LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS.” Neuro-Oncology, vol. 20, no. suppl_2, Oxford University Press (OUP), 2018, pp. i104–05. Crossref, doi:10.1093/neuonc/noy059.345.
Roskoski M, Gasinski D, Friedman H, Bigner D, Keir S. LGG-01. EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS. Neuro-Oncology. Oxford University Press (OUP); 2018. p. i104–i105.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
June 22, 2018
Volume
20
Issue
suppl_2
Start / End Page
i104 / i105
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences